Lyell Immunopharma Inc. – Indentures Watch

from S-3 25 pages Registration Rights Agreement by and Between Lyell Immunopharma, Inc. and Innovative Cellular Therapeutics Holdings Limited November 6, 2025 Registration Rights Agreement

from 10-Q 3 pages The Corporation Shall Furnish Without Charge to Each Stockholder Who So Requests a Statement of the Powers, Designations, Preferences and Relative, Participating, Optional or Other Special Rights of Each Class of Stock of the Corporation or Series Thereof and the Qualifications, Limitations or Restrictions of Such Preferences and/or Rights. Such Requests Shall Be Made to the Corporation’s Secretary at the Principal Office of the Corporation. Keep This Certificate in a Safe Place. if It Is Lost, Stolen,or Destroyed the Corporation Will Require a Bond Indemnity as a Condition to the Issuance of a Replacement Certificate. the Following Abbreviations, When Used in the Inscription on the Face of This Certificate, Shall Be Construed as Though They Were Written Out in Full According to Applicable Laws or Regulations

from 8-K 13 pages The Securities Represented Hereby Have Not Been Registered Under the Securities Act of 1933, as Amended, or the Securities Laws of Any State of the United States. the Securities May Not Be Sold, Offered for Sale, Pledged, Hypothecated, Transferred or Assigned in the Absence of an Effective Registration Statement for the Securities Under Applicable Securities Laws, or Unless Offered, Sold, Pledged, Hypothecated or Transferred Pursuant to an Available Exemption From the Registration Requirements of Those Laws. Pre-Funded Warrant to Purchase Common Stock Lyell Immunopharma, Inc

from S-3 18 pages Lyell Immunopharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Lyell Immunopharma, Inc. Form of Debt Securities Warrant Agreement

from S-3 20 pages Lyell Immunopharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Lyell Immunopharma, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3 20 pages Lyell Immunopharma, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Lyell Immunopharma, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3 55 pages Lyell Immunopharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20[•] Debt Securities

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-3ASR 17 pages Lyell Immunopharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Lyell Immunopharma, Inc. Form of Debt Securities Warrant Agreement

from S-3ASR 20 pages Lyell Immunopharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Lyell Immunopharma, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3ASR 19 pages Lyell Immunopharma, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Lyell Immunopharma, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3ASR 51 pages Lyell Immunopharma, Inc. and , as Trustee Form of Indenture Dated as of Debt Securities Lyell Immunopharma, Inc. Form of Indenture Article 1 Definitions

from S-8 28 pages Amended and Restated Bylaws of Lyell Immunopharma, Inc. (A Delaware Corporation) June 21, 2021

from S-8 6 pages Amended and Restated Certificate of Incorporation of Lyell Immunopharma, Inc

from S-1/A 2 pages The Corporation Shall Furnish Without Charge to Each Stockholder Who So Requests a Statement of the Powers, Designations, Preferences and Relative, Participating, Optional or Other Special Rights of Each Class of Stock of the Corporation or Series Thereof and the Qualifications, Limitations or Restrictions of Such Preferences and/or Rights. Such Requests Shall Be Made to the Corporation’s Secretary at the Principal Office of the Corporation. Keep This Certificate in a Safe Place. if It Is Lost, Stolen,or Destroyed the Corporation Will Require a Bond Indemnity as a Condition to the Issuance of a Replacement Certificate. the Following Abbreviations, When Used in the Inscription on the Face of This Certificate, Shall Be Construed as Though They Were Written Out in Full According to Applicable Laws or Regulations

from S-1 52 pages Amended and Restated Investors’ Rights Agreement

from DRS 52 pages Amended and Restated Investors’ Rights Agreement